Status:
COMPLETED
Pulse Sequence Development on 3T Magnetic Resonance Imaging/Spectroscopy
Lead Sponsor:
AHS Cancer Control Alberta
Collaborating Sponsors:
Cross Cancer Institute
Conditions:
Healthy
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to find ways to improve the appearance of tumours or markers that indicate the presence of tumours in Magnetic Resonance Imaging (MRI). Although based on the same technolo...
Eligibility Criteria
Inclusion
- healthy adult
Exclusion
- subject under 18 years of age
- subject pregnant, or may be pregnant
Key Trial Info
Start Date :
March 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2012
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00309504
Start Date
March 1 2006
End Date
February 1 2012
Last Update
February 26 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cross Cancer Institute
Edmonton, Alberta, Canada, T6G 1Z2